Recent News

• 06.05.2025 - PureTech to Present at the Jefferies Global Healthcare Conference
• 06.05.2025 - PureTech to Present at the Jefferies Global Healthcare Conference
• 05.22.2025 - PRTC to Present at Jefferies Healthcare Conference
• 05.22.2025 - PRTC to Present at Jefferies Healthcare Conference
• 05.20.2025 - PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial
• 05.20.2025 - PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial
• 04.30.2025 - PureTech to Present 2024 Annual Report and Financial Results
• 04.30.2025 - PureTech to Present 2024 Annual Report and Financial Results
• 04.30.2025 - PureTech Announces Annual Results for Year Ended December 31, 2024
• 04.30.2025 - PureTech Announces Annual Results for Year Ended December 31, 2024

Recent Filings

• 04.30.2025 - EX-99.1 EX-99.1
• 04.30.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.30.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 04.07.2025 - EX-99.1 EX-99.1
• 04.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]